Pay in 4 interest-free payments of $6.21 Learn more
:max_bytes(150000):strip_icc()/VWH-GettyImages-2126120259-c2442d334436484baa255439265b7fb1.jpg)
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
This assumption is desirable but will need to be confirmed in subsequent studies
WEGOVY tablets are indicated in combination with a reduced calorie diet and increased physical activity: to reduce the risk of major adverse CV events (CV death, non-fatal myocardial infarction, or non-fatal stroke) in adults with established CV disease and either obesity or overweight
Current standard-of-care therapies provide median survival of only 14-15 months, highlighting the urgent need for novel therapeutic approaches
People taking 9mg lost an average of 25.9% , while those taking 4mg lost an average of 19.0%
US$ 21.84
US$ 25.80
US$ 23.09
US$ 26.53
US$ 22.29
